Mitra Gavgani
VP, PHARM SRVCS & CLIN OPS at JOHNS HOPKINS PHARMAQUIP INC · MD · Healthcare
$314K
Peak Total Compensation
7
Years Tracked
4x
vs. Median Household
Mitra Gavgani has appeared in compensation disclosures over 7 years of available data (2016–2023). Total compensation changed from $192,591 to $314,407 - a 63.3% increase.
Peak total compensation of $314,407 equals 4x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2023 | JOHNS HOPKINS PHARMAQUIP INC | VP, PHARM SRVCS & CLIN OPS | $280,455 | $33,952 | $314,407 |
| 2022 | JOHNS HOPKINS PHARMAQUIP INC | VICE PRESIDENT PHARMACY SERV | $247,365 | $25,711 | $273,076 |
| 2020 | JOHNS HOPKINS PHARMAQUIP INC | VICE PRESIDENT PHARMACY SERV | $215,004 | $23,346 | $238,350 |
| 2019 | JOHNS HOPKINS PHARMAQUIP INC | VICE PRESIDENT PHARMACY SERV | $234,922 | $28,164 | $263,086 |
| 2018 | JOHNS HOPKINS PHARMAQUIP INC | VICE PRESIDENT PHARMACY SERV | $200,628 | $26,614 | $227,242 |
| 2017 | JOHNS HOPKINS PHARMAQUIP INC | SR DIR OF INFUSION SERVICES | $182,838 | $26,453 | $209,291 |
| 2016 | JOHNS HOPKINS PHARMAQUIP INC | DIRECTOR OF INFUSION SERVI | $167,117 | $25,474 | $192,591 |
Peers at JOHNS HOPKINS PHARMAQUIP INC
| Name | Title | Peak Comp. |
|---|---|---|
| Mary G Myers | PRESIDENT/TRUSTEE | $1.0M |
| Daniel B Smith | PRESIDENT/TRUSTEE | $780K |
| Victoria Semanie | FORMER OFFICER | $461K |
| Nathan Thompson | VP, ADMINISTRATIVE SRVCS | $320K |
| Penny Carey | EXEC DIR HME/RT | $303K |
| Kristopher Rusinko | EXEC DIR PHARMACY | $273K |
| James Van Daniker | VP, FINANCE & TREASURER | $266K |
| Toni Carter-Radden | DIR OF OPERATIONS | $248K |
| Wendy Jackson | PHARMACY OPS COORDINATOR | $229K |
| Jean Feels | DIRECTOR OF EDUCATION | $224K |
Email Alerts
Get notified about Mitra Gavgani
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →